Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

NCT07495852 is registered in ClinicalTrials.gov with Glaukos Corporation as lead sponsor.

NCT NCT07495852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07495852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Lead sponsor
Glaukos Corporation
Phase
Phase 3
Overall status
Recruiting
Start date
February 17, 2026
Completion date
March 31, 2032
Enrollment
510 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma